Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu High-tech Zone Yaogong Pharmaceutical Biotechnology Research Institute is a specialized research organization located in the Chengdu High-tech Industrial Development Zone, China. The institute focuses on the research and development of innovative pharmaceuticals, high-end generic drugs, and advanced drug delivery technologies such as liposomes and microspheres. It provides a range of technical services including pharmaceutical formulation development, quality control, and consistency evaluation for the Chinese pharmaceutical industry. By integrating academic research with industrial application, the institute aims to accelerate the commercialization of novel therapeutic candidates and improve the quality of domestic generic medications. It serves as a key R&D hub within the Sichuan biotech ecosystem, collaborating with both local enterprises and academic institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu High-tech Zone Yaogong Pharmaceutical Biotechnology Research Institute.